WO2003099771A3
(en )
2004-04-01
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2001085106A3
(de )
2002-08-01
Kosmetisches mittel enthaltend 2-furanonderivate
WO2002085299A3
(en )
2003-10-16
Therapeutic treatments using the direct application of antimicrobial metal compositions
RU2000102308A
(ru )
2001-11-10
Лосьон для стимулирования роста волос и предупреждения потери волос, связанной с андрогенной алопецией
WO2001058412A3
(de )
2002-01-17
Extrakte von rückständen aus der weinherstellung
WO2000038625A3
(en )
2000-11-16
Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
HUP0302508A3
(en )
2007-03-28
Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
CA2436540A1
(en )
2002-05-10
Pharmaceutical compositions based on anticholinergics and corticosteroids
WO2004108075A3
(en )
2005-03-10
Self-warming or self-heating cosmetic and dermatological compositions and method of use
HUP0400548A3
(en )
2007-05-29
Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
WO2001047473A3
(de )
2002-02-14
Magnesium-angereicherter extrakt aus der blaualge spirulina und seine verwendung in kosmetischen und dermatologischen mitteln zur haut- und körperpflege
WO2003037288A3
(fr )
2003-10-09
Composition cosmetique mimant le sebum, et utilisations
EP1172084A3
(de )
2002-08-14
Kosmetische und dermatologische Zubereitung zur Beseitigung vom Sebum
WO2003026605A3
(fr )
2003-11-27
Composition cosmetique pour le soin de la peau et des cheveux de l'homme
WO2002051379A3
(en )
2003-03-13
Thixotropic nasal spray
WO2004075867A3
(de )
2004-10-28
Zubereitungen eines extraktes von eperua falcata und/oder dessen inhaltstoffe enthaltend
WO2004058282A3
(fr )
2004-08-19
Procede d’obtention d’un principe actif a partir de mentha piperita presentant des capacites apaisantes
HUP9802897A3
(en )
2001-08-28
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
JP2002325828A5
(https= )
2008-04-03
JP2002114686A5
(https= )
2007-10-18
JP2003523397A5
(https= )
2008-03-13
HUP0102987A3
(en )
2003-02-28
Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
AU2001237768A1
(en )
2001-09-12
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
EP1616559A4
(en )
2007-01-17
DESODRATING MEDIUM
WO2004052331A3
(fr )
2004-08-12
Utilisation d'un extrait de miellat de coton comme ingredient acitif